While current U.S. guidelines recommend cervical cancer screening stop at age 65, less than 1 in 3 women aged 64-66 met the criteria to safely discontinue screening, according to research published June 7 in Gynecologic Oncology.

Here are four recent cancer care and research-related partnerships and affiliations formed since May 11. 

Throughout the past year, 70 percent of oncologists surveyed reported some form of sexual harassment by their peers or superiors, according to findings recently published in the Journal of Clinical Oncology.

AstraZeneca's Lynparza drug cut the combined risk of recurrence of cancer or death from any cause by 42 percent among early-stage breast cancer patients with certain mutations, compared to those who received a placebo, according to research published June 3 in The New England Journal of Medicine. 

The Sidney Kimmel Cancer Center in Philadelphia, part of Jefferson Health, has named Andrew Aplin, PhD, as deputy director of scientific strategy.

The National Cancer Institute removed Axel Grothey, MD, from his position as co-chair of a steering committee May 27 after reports surfaced that the physician had inappropriate sexual relationships with mentees while working at Rochester, Minn.-based Mayo Clinic, Medscape reported June 1. 

In an era of infinite challenges and finite resources, health systems must employ a rigorous approach to strategic and facility planning. This is particularly true for oncology, where the pace of change and innovation is unprecedented.

An odor-based test developed by researchers at the University of Pennsylvania's medical school in Philadelphia identified cancer cells with up to 95 percent accuracy, according to findings set to be presented June 4 at the 2021 American Society of Clinical Oncology annual meeting. 

Biosimilars are FDA-approved medicines that are rigorously tested and subject to the same quality manufacturing standards as reference medicines.

A story about an influx of progressing cancer diagnoses that slipped through the cracks amid earlier stages of the pandemic was Becker's most-read oncology story in May. 

Healthcare in the US is often a double-edged sword. Recently, it’s gotten sharper at both ends. 

In an era of infinite challenges and finite resources, health systems must employ a rigorous approach to strategic and facility planning.

Saint Joseph Mount Sterling (Ky.), part of Lexington, Ky.-based CHI Saint Joseph Health, has partnered with Cleveland Clinic Cancer Center to provide access to specialized care for the region's cancer patients.

As many as 10 percent of insured cancer survivors delayed follow-up care in the previous 12 months due to costs such as deductibles or copays, according to a recent study published in Cancer Medicine.

Rhode Island has the highest percentage of cancer screenings among U.S. adults between the ages of 65 and 75, while Wyoming falls furthest from the national average of 74.1 percent, according to the United Health Foundation. 

Los Angeles-based USC Norris Comprehensive Cancer Center is creating cancer wellness hubs throughout the city with the goal of reducing health disparities and improving outcomes. 

A community outreach engagement program at Penn Medicine's Abramson Cancer Center in Philadelphia increased the percentage of Black patients in clinical trials from 12 to 24 percent, the health system said May 19. 

Breast cancer patients receiving chemotherapy had about the same risk of contracting COVID-19 as those taking cancer drugs that don't weaken the immune system, according to a study led by NYU Langone Health researchers set to be presented June 4 at the 2021 American Society of Clinical Oncology's 2021 Annual Meeting. 

HPV vaccination rates among adolescents already lagged behind those of other recommended vaccines, with the COVID-19 pandemic further exacerbating it. Now, 72 U.S. cancer centers are urging parents and physicians to prioritize getting children back on track with the vaccine this summer. 

Cervical cancer rates have dropped 1 percent annually since 2001, likely due to clear screening and HPV vaccination guidelines, while other HPV-related cancers without standardized screening guidelines are on the rise, according to research set to be presented at the 2021 American Society of Clinical Oncology Annual Meeting.